Top Markets
#1 DogBull DogBull +104.72%
#2 Siacoin Siacoin +47.20%
#3 UnifAI Network UnifAI Network +46.69%
#4 ADO Protocol ADO Protocol +46.51%
#5 MarsCoin MarsCoin +40.40%
#6 Magma Finance Magma Finance +27.08%
#7 Useless Coin Useless Coin +25.34%
#8 Ontology Gas Ontology Gas +19.36%
#9 Nockchain Nockchain +17.04%
#10 Arowana Arowana +15.55%
Coin of the day
DogBull DogBull
Settings
Language
ENGLISH
Currency
USD
Theme
CMIC HOLDINGS Co., Ltd. CMIC HOLDINGS Co., Ltd.

CMIC HOLDINGS Co., Ltd.

2309
Rank in Stocks #16496
Based in Tokyo, Japan, CMIC HOLDINGS Co., Ltd. serves as a leading provider of... Based in Tokyo, Japan, CMIC HOLDINGS Co., Ltd. serves as a leading provider of extensive services to the pharmaceutical industry within Japan. Its operational framework is structured across five strategic segments: Contract Research Organization (CRO), Contract Development and Manufacturing Organization (CDMO), Contract Sales Organization (CSO), Healthcare, and Innovative Pharma Model. Through its CRO capabilities, the company orchestrates comprehensive clinical trial services, encompassing everything from clinical operations, precise data management, and medical writing to patient recruitment, pharmacovigilance, project leadership, and stringent audit and quality assurance, alongside expert statistical analysis. Additionally, it offers critical consulting expertise in areas like clinical site network development, drug formulation, health economics, market entry strategies, and regulatory navigation, including advice on national health insurance pricing for medical devices and in vitro diagnostics. CMIC's CDMO division is instrumental in drug development and manufacturing, handling commercial supply, contract development, investigational product manufacturing, and specialized tasks such as packaging, labeling, release and stability testing, and technology transfer, bolstered by advanced formulation, process, and analytical development services. The company also operates sophisticated laboratory facilities, delivering bioanalysis, GLP/GMP analysis, and studies on biomarkers, large and small molecules, oligonucleotides, and conducting thorough toxicity, safety pharmacology, and non-clinical assessments. Within its Healthcare segment, CMIC focuses on patient and healthcare support, offering innovative solutions like drug adherence programs, specialized health platforms (harmo, Helc+), extensive prescription drug databases, and personalized health checks (selcheck). Beyond these, its portfolio includes post-marketing surveillance, self-inspection, regulatory affairs consulting, regulatory submissions and correspondence, sales and marketing support, and efficient clinical research coordinating and site management services. Demonstrating its commitment to innovation, CMIC HOLDINGS Co., Ltd. has entered into a strategic partnership with Science 37, Inc. to advance the adoption of decentralized clinical trials, thereby accelerating the progress of new treatment development. The company was originally established in 1985.
Share Price
$17.25
Last synced: 2024-03-27
Market Cap
$291.27M
Change (1 day)
-0.46%
Change (1 year)
0.00%
Country
JP
Trade CMIC HOLDINGS Co., Ltd. (2309)

Category

Healthcare
P/E ratio for CMIC HOLDINGS Co., Ltd. (2309)
P/E ratio as of 2026 TTM: 0
According to CMIC HOLDINGS Co., Ltd. latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 0. At the end of 2026 the company had a P/E ratio of 0.
P/E ratio history for CMIC HOLDINGS Co., Ltd. from 2026 to 2026
P/E ratio at the end of each year
Year P/E Ratio Change
Not enough data for the provided dates.
P/E ratio for similar companies or competitors
Company P/E Ratio P/E Ratio Difference Country
Thermo Fisher Scientific Inc. Thermo Fisher Scientific Inc.
Thermo Fisher Scientific Inc.
TMO.US
 33.14 -
US
Danaher Corporation Danaher Corporation
Danaher Corporation
DHR.US
 37.80 -
US
WuXi AppTec Co., Ltd. WuXi AppTec Co., Ltd.
WuXi AppTec Co., Ltd.
603259.SS
 - -
CN
Natera, Inc. Natera, Inc.
Natera, Inc.
NTRA.US
 -236.74 -
US
IDEXX Laboratories, Inc. IDEXX Laboratories, Inc.
IDEXX Laboratories, Inc.
IDXX.US
 39.09 -
US
How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.

Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.